Clinical Trials Browser

Phase 2 × Carcinoma, Non-Small-Cell Lung × onartuzumab × Clear all

NCT00854308 2017-03-31

A Study of MetMAb Administered to Patients With Advanced Non-Small Cell Lung Cancer, in Combination With Tarceva (Erlotinib)

Phase 2 Completed

137 enrolled 11 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms